It is worth noting that the eGene SRD5A3 was reported as a risk gene for prostate cancer in our transcriptome-wide association study (TWAS) analysis using two distinct prostate cancer GWAS studies (Additional file 5: Fig. S3A) [19–21]. Here, SRD5A3 is linked to prostate carcinoma.